JSR Life Sciences expands Amsphere A3 production capacity in Belgium

JSR Life Sciences announced plans to expand production capacity of Amsphere A3 protein-A chromatography resin at its Belgium subsidiary JSR Micro NV, increasing capacity by 6 times. Phase one construction started earlier in 2017, with full operational status expected in 2018 and total additional capacity by fiscal year 2019.

“JSR Life Sciences (JLS), the global life sciences focused division of JSR Corporation, today announced plans for expansion of its production capabilities of Amsphere TM A3 protein-A chromatography resin at JSR’s Belgium subsidiary, JSR Micro NV.”biospace.com

• 1 source
• biospace.comJSR Life Sciences Expands Amsphere A3 Production Capacity - BioSpaceBioSpace Editorial StaffMay 9, 2017

Summarized from public sources; check the original articles before acting on it.